- American City Business Journals•2 hours ago
On the eve of its second quarter earnings report, the state’s biggest medical device company, Boston Scientific, announced that it acquired an 88-employee Burlington firm that makes equipment for a non-opiod treatment for pain known as radiofrequency ablation. Marlborough-based Boston Scientific (BSX) said this morning that it bought Cosman Medical but did not provide specifics of the deal. It said that “the medical team and products of Cosman would become part of its neuromodulation business.” In the first three months of the year, sales of Boston Scientific’s neuromodulation products — including spinal cord stimulator systems for chronic pain as well as deep brain stimulation systems for Parkinson’s disease, dystonia and essential tremor — made up about 6 percent of the company’s total revenue, or $121 million.
- Benzinga•5 hours ago
Boston Scientific Corporation (NYSE: BSX ) disclosed that it purchased the privately-held Cosman Medical, Inc., manufacturer of radiofrequency ablation (RFA) systems. Both the companies have not disclosed ...
|Bid||23.71 x 8400|
|Ask||23.72 x 3900|
|52wk Range||14.18 - 24.45|
|Day's Range||23.52 - 24.11|
|Avg Vol (3m)||11,522,060|
As of 3:11 PM EDT. NYSE Real Time Price. Market open.